Table 2 Clinical response for the 120 patients who received Bravelle® and the 118 patients who received Follistim®.
Parameter | Bravelle® (n = 120) | Follistim® (n = 118) | P-value |
|---|---|---|---|
Day 1 of stimulationa | |||
Serum FSH (mIU/mL) | 4.6+1.7 | 4.9+2.2 | 0.155 |
Serum LH (mIU/mL) | 4.6+2.9 | 4.6+2.6 | 0.894 |
Serum E2 (pg/mL) | 23.7 +11.8 | 22.6 +10.4 | 0.442 |
Mean days of FSH therapy | 9.1 ± 1.6 | 9.2 ± 1.5 | 0.645 |
Mean total dose of FSH (IU) | 2313.8 ± 837.1 | 2262.7 ± 736.8 | 0.613 |
Mean peak estradiol levels (pg/mL) | 1893.4 ± 1154.8 | 1888.9 ± 1131.9 | 0.817 |